Endonovo Therapeutics

Endonovo Therapeutics

Biotechnology, 6320 Canoga Ave, Woodland Hills, California, 91367, United States, 11-50 Employees

endonovo.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: 80********

Who is ENDONOVO THERAPEUTICS

Endonovo Therapeutics (OTCQB: ENDV) is an innovative biotechnology company developing a bioelectronic approach to regenerative medicine. Endonovo's ImmunotronicsTM platform is a non-invas...

Read More

map
  • 6320 Canoga Ave, Woodland Hills, California, 91367, United States Headquarters: 6320 Canoga Ave, Woodland Hills, California, 91367, United States
  • 2011 Date Founded: 2011
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2834 | NAICS Code: 325412 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from ENDONOVO THERAPEUTICS

Endonovo Therapeutics Org Chart and Mapping

Employees

Larry Block

Director of Sales and Marketing

Ira Weisberg

President and Chief Commercial Officer

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Endonovo Therapeutics

Answer: Endonovo Therapeutics's headquarters are located at 6320 Canoga Ave, Woodland Hills, California, 91367, United States

Answer: Endonovo Therapeutics's phone number is 80********

Answer: Endonovo Therapeutics's official website is https://endonovo.com

Answer: Endonovo Therapeutics's revenue is $1 Million to $5 Million

Answer: Endonovo Therapeutics's SIC: 2834

Answer: Endonovo Therapeutics's NAICS: 325412

Answer: Endonovo Therapeutics has 11-50 employees

Answer: Endonovo Therapeutics is in Biotechnology

Answer: Endonovo Therapeutics contact info: Phone number: 80******** Website: https://endonovo.com

Answer: Endonovo Therapeutics (OTCQB: ENDV) is an innovative biotechnology company developing a bioelectronic approach to regenerative medicine. Endonovo's ImmunotronicsTM platform is a non-invasive, non-implantable bioelectronic device for treating/preventing vital organ failure through the reduction of inflammation and necrosis, and the promotion of regeneration. Endonovo's CytotronicsTM platform provides for a method of expanding and manipulating cells using simulated microgravity and Time-Varying Electromagnetic Fields (TVEMF) for tissue engineering and cell therapies.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access